P. А. Shesternya

643 citations
34 papers · 159 · h-index 6

Impact in

  • Rheumatology
    • Spondyloarthritis Studies and Treatments
    • Rheumatoid Arthritis Research and Therapies
  • Immunology
    • Psoriasis: Treatment and Pathogenesis
    • Biosimilars and Bioanalytical Methods

Papers in

  • Immunology 15
    • Psoriasis: Treatment and Pathogenesis 7
    • Biosimilars and Bioanalytical Methods 3
  • Rheumatology 14
    • Rheumatoid Arthritis Research and Therapies 10
    • Spondyloarthritis Studies and Treatments 8
    • Osteoarthritis Treatment and Mechanisms 2
Co-authors
М. М. Петрова (5 shared papers)Р. Ф. Насырова (2 shared papers)N. А. Shnayder (2 shared papers)Е. А. Пожиленкова (2 shared papers)Т. А. Раскина (4 shared papers)Dae‐Hyun Yoo (1 shared paper)S. Radominski (1 shared paper)В. Н. Максимов (4 shared papers)
Journals
Annals of the Rheumatic Diseases (5 papers)Biomedicines (1 paper)Molecules (1 paper)BioDrugs (1 paper)Rheumatology and Therapy (1 paper)
Partner nations
RussiaBelarusSouth Korea

In The Last Decade

P. А. Shesternya

24 papers receiving 155 citations

Peers

P. А. Shesternya
Comparison fields: 5 of 58
  • Rheumatology 56
  • Immunology 75
  • Hematology 30
  • Internal Medicine 7
  • Cardiology and Cardiovascular Medicine 26
Replace C. Florio with:
C. Florio Italy
Malorie Chabot-Blanchet Canada
Luciano Ibba Italy
L. Méry‐Bossard France
Buu Truong United States
Raili Müller Estonia
A A Skoromets Russia
Feng Ding China
Maxime Hoffmann France
Sanjay Gupte India
P. А. Shesternya relative to C. Florio Italy C. Florio's profile →
Citations per field
00.5×2×4×6×
C. Florio · 1×
Citations per year

Countries citing papers authored by P. А. Shesternya

Since Specialization
Citations

This map shows the geographic impact of P. А. Shesternya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. А. Shesternya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. А. Shesternya more than expected).

Fields of papers citing papers by P. А. Shesternya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. А. Shesternya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. А. Shesternya. The network helps show where P. А. Shesternya may publish in the future.

Co-authors

The 25 scholars most cited alongside P. А. Shesternya, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with P. А. Shesternya Line = papers co-authored together P. А. Shesternya links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and Safety of Switching from Innovator Rituximab to Biosimilar CT-P10 Compared with Continued Treatment with CT-P10: Results of a 56-Week Open-Label Study in Patients with Rheumatoid Arthritis
BioDrugs ·Won Park, Chang‐Hee Suh, Seung Cheol Shim, Francisco Fidencio Cons Molina, Sławomir Jeka, Francisco G. Medina-Rodriguez, Paweł Hrycaj, Piotr Wiland, Eun Young Lee, P. А. Shesternya, Volodymyr Kovalenko, L. Myasoutova, Marina Stanislav, S. Radominski, Mie Jin Lim, Jung‐Yoon Choe, Sang Joon Lee, Sungyoung Lee, Sung‐Hwan Kim, Dae‐Hyun Yoo
201736
2
Primary efficacy of netakimab, a novel interleukin-17 inhibitor, in the treatment of active ankylosing spondylitis in adults.
PubMed ·Ш. Ф. Эрдес, Е. Л. Насонов, Е. В. Кундер, Andrey Pristrom, Nikolay Soroka, P. А. Shesternya, Tatiana Dubinina, С. А. Смакотина, Т. А. Раскина, D. G. Krechikova, Tatiana Povarova, Tatiana Plaksina, И. Г. Гордеев, Mazurov Vi, O. V. Reshetko, Е. В. Зонова, A. Eremeeva, E. V. Chernyaeva, Tatiana Makulova, Roman Ivanov
202034
3
Using Pharmacogenetics of Direct Oral Anticoagulants to Predict Changes in Their Pharmacokinetics and the Risk of Adverse Drug Reactions
Biomedicines ·N. А. Shnayder, М. М. Петрова, P. А. Shesternya, A. V. Savinova, Е. Н. Бочанова, O. V. Zimnitskaya, Е. А. Пожиленкова, Р. Ф. Насырова
202123
4
The Role of Single-Nucleotide Variants of NOS1, NOS2, and NOS3 Genes in the Comorbidity of Arterial Hypertension and Tension-Type Headache
Molecules ·N. А. Shnayder, М. М. Петрова, Polina V. Moskaleva, P. А. Shesternya, Е. А. Пожиленкова, Р. Ф. Насырова
202115
5
Association of ADRB1 Gene Polymorphism with Atrial Fibrillation
Genetic Testing and Molecular Biomarkers ·Svetlana Nicoulina, Shul'man Va, P. А. Shesternya, А. А. Чернова, А. Б. Салмина, Oksana Issachenko, В. Н. Максимов, М. И. Воевода
20107
6
OP0028 Efficacy and safety of bcd-085, a novel il-17 inhibitor, in ankylosing spondylitis. results of phase 2 clinical study
Annals of the Rheumatic Diseases ·Mazurov Vi, Ш. Ф. Эрдес, Е. В. Кундер, N. Soroka, P. А. Shesternya, С. А. Смакотина, Т. А. Раскина, D. G. Krechikova, Т. В. Дубинина, A. Eremeeva, E. Dokukina, E. V. Chernyaeva, Roman Ivanov
20187
7
The efficacy and safety of intra-articular application of a combination of sodium hyaluronate and chondroitin sulfate for osteoarthritis of the knee: a multicenter prospective study
SHILAP Revista de lepidopterología ·Л. И. Алексеева, Н. Г. Кашеварова, Е. А. Таскина, E. P. Sharapova, С Г Аникин, E. Strebkova, Т. А. Раскина, E. V. Zonova, Э. Н. Оттева, С. С. Родионова, A. N. Torgashin, Yu. V. Buklemishev, Е. Шмидт, P. А. Shesternya, А. В. Наумов, N. V. Zagorodniy, А. М. Лила
20205
8
Features of Peripheral Blood Th-Cell Subset Composition and Serum Cytokine Level in Patients with Activity-Driven Ankylosing Spondylitis
Pharmaceuticals ·P. А. Shesternya, А. А. Савченко, Olga D. Gritsenko, Alexandra O. Vasileva, Igor Kudryavtsev, Alena A. Masterova, Dmitry Isakov, А. Г. Борисов
20223
9
SAT0146 Randomised double-blind study shows comparable long-term efficacy and safety between rituximab biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: 48-week results
Annals of the Rheumatic Diseases ·Chang‐Hee Suh, Elias Chalouhi El Khouri, Pedro C. Miranda, Francisco Fidencio Cons Molina, P. А. Shesternya, Francisco G. Medina-Rodriguez, Piotr Wiland, Sławomir Jeka, José Chávez-Corrales, Teresa von Linde, Paweł Hrycaj, Ihor Hospodarskyy, Mauricio Abello-Banfi, Janusz Jaworski, M Piotrowski, W Park, Seung Cheol Shim, SJ Lee, Shing Yip Lee, DH Yoo
20173
10
Association of RS1800470 polymorphic variants of the transforming growth factor β1 (TGF-β1) gene with the severity of coronary atherosclerosis
Russian Journal of Cardiology ·D. A. Brusentsov, S. Yu. Nikulinа, P. А. Shesternya, А. А. Чернова
20183
11
Clinical application of chromosome 9p21.3 genotyping in patients with coronary artery disease
Experimental and Therapeutic Medicine ·S. Yu. Nikulinа, Ivan Artyukhov, P. А. Shesternya, Oksana A. Gavrilyuk, В. Н. Максимов, M. I. Voyevoda, D. A. Brusentsov
20193
12
GENETIC ASPECTS OF MYOCARDIAL INFARCTION: PROBLEMS AND PERSPECTIVES
SHILAP Revista de lepidopterología ·P. А. Shesternya, Shul'man Va, S. Yu. Nikulinа
20172
13
Management of patients with rheumatoid arthritis in real clinical practice: Switching from interleukin 6 receptor inhibitors to interleukin 6 inhibitor (olokizumab)
SHILAP Revista de lepidopterología ·А. А. Баранов, I. B. Vinogradova, О. Н. Аношенкова, О. В. Антипова, Е. А. Богданова, Y. Y. Grabovetskaya, Е. П. Иливанова, A. N. Kalyagin, I. N. Kushnir, N. A. Lapkina, M. V. Mokrousova, O. B. Nesmeyanova, Н. М. Никитина, P. А. Shesternya, N. V. Yudina, Eugen Feist, Е. Л. Насонов
20232
14
PARALLEL PANDEMIC: PSYCHOLOGICAL FACILITATION IN MEDICAL ASSISTANCE
Sibirskiy psikhologicheskiy zhurnal ·О. В. Волкова, P. А. Shesternya
20212
15
CLINICAL SIGNIFICANCE OF CORONARY ARTERY DISEASE GENETIC MARKERS: REALITY OR FAR FUTURE?
Russian Journal of Cardiology ·P. А. Shesternya, S. Yu. Nikulinа, V. A. Shulman, А. С. Сергеева, Alina Demkina, В. Н. Максимов, М. И. Воевода
20142
16
THE EFFECTIVENESS OF VACCINATION AGAINST THE NEW CORONAVIRUS INFECTION (COVID-19) IN THE KRASNOYARSK TERRITORY
Ekologiya Cheloveka (Human Ecology) ·A.A. Mironova, А.Н. Наркевич, P. А. Shesternya
20212
17
The clinical status and working capacity in patients included in the All-Russian Psoriatic Arthritis Registry
SHILAP Revista de lepidopterología ·Е. Yu. Loginova, Т. В. Коротаева, Yu. L. Kоrsakova, Е. Е. Gubar, P. O. Tremaskina, E. Vasilenko, Igal Kushnir, I. M. Patkikeeva, Snezana Kudishina, P. А. Shesternya, Petrov Av, Н. А. Кузнецова, Е. Л. Насонов
20202
18
Guselkumab in Biologic-Naïve Patients with Active Psoriatic Arthritis in Russia: A Post Hoc Analysis of the DISCOVER-1 and -2 Randomized Clinical Trials
Rheumatology and Therapy ·Philip J. Mease, Т. В. Коротаева, P. А. Shesternya, М. М. Кохан, Anton Rukavitsyn, D. A. Vasil’chenkov, Mohamed Sharaf, F. Lavie, Atul Deodhar
20241
19
PREDICTIVE ROLE OF CHROMOSOME 9P21.3 POLYMORPHISMS AND THEIR ASSOCIATION WITH FAMILY HISTORY OF CORONARY HEART DISEASE IN PATIENTS WITH MYOCARDIAL INFARCTION
SHILAP Revista de lepidopterología ·P. А. Shesternya, Shul'man Va, S. Yu. Nikulinа, Elena Martynova, Alina Demkina, П. С. Орлов, В. Н. Максимов, М. И. Воевода
20121
20
Strategies and trends for organization of medical and psychological assistance in post-pandemic period
Siberian medical review ·О. В. Волкова, P. А. Shesternya
20201

About P. А. Shesternya

P. А. Shesternya is a scholar working on Immunology, Rheumatology, Epidemiology, Psychiatry and Mental health and Molecular Biology, having authored 34 papers that have together received 159 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (10 papers), Spondyloarthritis Studies and Treatments (8 papers), Psoriasis: Treatment and Pathogenesis (7 papers), Healthcare Systems and Public Health (3 papers), Autoimmune and Inflammatory Disorders Research (3 papers), Biosimilars and Bioanalytical Methods (3 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (3 papers) and Osteoarthritis Treatment and Mechanisms (2 papers). The work is most often cited by research in Rheumatology (56 citations), Immunology (75 citations), Hematology (30 citations), Internal Medicine (7 citations) and Cardiology and Cardiovascular Medicine (26 citations). P. А. Shesternya has collaborated with scholars based in Russia, Belarus and South Korea. Frequent co-authors include М. М. Петрова, Р. Ф. Насырова, N. А. Shnayder, Е. А. Пожиленкова, Т. А. Раскина, Dae‐Hyun Yoo, S. Radominski, В. Н. Максимов, Paweł Hrycaj and А. А. Чернова. Their work appears in journals such as Annals of the Rheumatic Diseases, Biomedicines, Molecules, BioDrugs and Rheumatology and Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. FlorioBreakdown of academic impact, for papers by Malorie Chabot-BlanchetBreakdown of academic impact, for papers by Luciano IbbaBreakdown of academic impact, for papers by L. Méry‐BossardBreakdown of academic impact, for papers by Buu TruongBreakdown of academic impact, for papers by Raili MüllerBreakdown of academic impact, for papers by A A SkorometsBreakdown of academic impact, for papers by Feng DingBreakdown of academic impact, for papers by Maxime HoffmannBreakdown of academic impact, for papers by Sanjay Gupte